• By ICR Secretariat
  • Posted Thursday, April 14, 2022

Hundreds of urothelial cancer patients to receive new treatment

https://www.pharmatimes.com/news/hundreds_of_urothelial_cancer_patients_to_receive_new_treatment_1389878

NICE recommends avelumab as treatment for adults with locally advanced or metastatic urothelial cancer